CVS Health Corporation logo CVS - CVS Health Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
2
BUY 33
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $100.33 DETAILS
HIGH: $110.00
LOW: $90.00
MEDIAN: $101.00
CONSENSUS: $100.33
UPSIDE: 7.58%

Stock News

CVS Health, Diocese of Camden, and The Walters Group Unite to Bring Senior Affordable Housing to Williamstown, New Jersey

CVS Health, Diocese of Camden, and The Walters Group Unite to Bring Senior Affordable Housing to Williamstown, New Jersey

CVS Health's collaboration with Diocesan Housing Services Corporation and The Walters Group supports the new construction of Mews at St. Mary WOONSOCKET, R.I., May 21, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today joined The Diocesan Housing Services Corporation (DHSC) of the Diocese of Camden, The Walters Group, The United States Department of Housing and Urban Development (HUD), the New Jersey Housing and Mortgage Finance Agency (NJHMFA), and community leaders to celebrate the grand opening and building dedication of The Mews at St. Mary, a new 75-unit senior affordable housing property located in Williamstown, New Jersey.

May 21, 2026 05:00 AM prnewswire.com
CVS Health Reinforces Longstanding Support for the Military Community

CVS Health Reinforces Longstanding Support for the Military Community

Delivering care, connection, and opportunity to military ‑ connected families nationwide WOONSOCKET, R.I., May 20, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) is reaffirming its commitment to supporting service members, veterans, their families and caregivers through a comprehensive approach that spans health care access, community‑based solutions, purpose‑driven engagement and economic opportunity.

May 20, 2026 04:30 AM prnewswire.com
CVS Health study reveals a need for greater digital health literacy for Medicare members

CVS Health study reveals a need for greater digital health literacy for Medicare members

Majority of respondents believe that low digital literacy is having a negative impact on their ability to manage their health  CVS Health continues to launch innovative digital offerings to help members access care, as part of its $20 billion technology investment, announced in 2025 WOONSOCKET, R.I., May 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS), today released "Navigating the Digital Health Literacy Gap," a research-based white paper revealing a significant gap between older Americans' current ability to navigate digital health tools and their interest and openness to learning more.

May 18, 2026 04:30 AM prnewswire.com
Omnicare Receives Court Approval for Sale of Business to GenieRx

Omnicare Receives Court Approval for Sale of Business to GenieRx

WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE: CVS), today announced that following a comprehensive sale process, the U.S. Bankruptcy Court for the Northern District of Texas (the "Court") has approved the sale of the Company's business to GenieRx Holdings LLC ("GenieRx"), a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services.

May 13, 2026 12:00 PM prnewswire.com
MinuteClinic highlights access and outcomes in clinically supervised weight-loss program

MinuteClinic highlights access and outcomes in clinically supervised weight-loss program

In-person and virtual services support chronic disease prevention and long-term metabolic health WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic®, the medical clinic inside select CVS Pharmacy® (NYSE: CVS) locations, is highlighting its clinically supervised weight-loss program to support earlier intervention and more accessible preventive care.

May 13, 2026 04:00 AM prnewswire.com
CVS Health: Still Cheap And Signs Of Improvement

CVS Health: Still Cheap And Signs Of Improvement

CVS Health Corporation remains deeply undervalued despite persistent headwinds and an 11-year correction, with intrinsic value estimates well above current prices. Q1 2026 results showed 6.2% revenue growth and a 63.1% EPS increase, prompting management to raise full-year guidance for revenue, cash flow, and earnings. Margins and the medical benefit ratio are showing early signs of recovery, supporting management's and analysts' renewed optimism for double-digit EPS growth.

May 10, 2026 06:09 PM seekingalpha.com

Price Targets